A stealth attack tool for preventing clinical drug resistance through a unique s...
A stealth attack tool for preventing clinical drug resistance through a unique self regenerating surface
Outbreaks of clinical infections affect many thousands of patients in Europe yearly. The present effective treatment for infections is large doses of systemically applied drugs. There is a high risk of recurring infections and bio...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MAT2015-67648-R
NANORECUBRIMIENTOS HIBRIDOS CON MEJORADA EFICIENCIA ANTIMICR...
121K€
Cerrado
CYTAMED
A unique and universal antibacterial coating for prevention...
71K€
Cerrado
NOVO
Novel approaches for prevention and degeneration of pathogen...
4M€
Cerrado
AIMed
Antimicrobial Integrated Methodologies for orthopaedic appli...
4M€
Cerrado
COATIM
Development of antibiofilm coatings for implants
4M€
Cerrado
PID2019-104111RB-I00
RECUBRIMIENTOS DE HIDROGEL QUE CONTIENEN NANOPARTICULAS ANTI...
157K€
Cerrado
Información proyecto BACATTACK
Líder del proyecto
TEKNOLOGISK INSTITUT
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Outbreaks of clinical infections affect many thousands of patients in Europe yearly. The present effective treatment for infections is large doses of systemically applied drugs. There is a high risk of recurring infections and biofilm formation for patients dependent on long term in-dwelling catheters and the extended dependency on antibiotics result in clinical drug resistance. We present a new tool for minimizing drug resistance by upgrading existing and future medical devices through a unique self-regenerating surface that prevents biofilm formation by a two-fold stealth attack mechanism. This will be achieved by an interpenetrating polymer network (IPN) that allows for long term release of a range of antimicrobial strategies, such as antimicrobial peptides (AMPs) . The IPNs contain hydrogels where the AMP is stored until the release starts at the insertion of the device with an expected long-term effect. The first line of defence will be a fixed galvanic noble metal alloy coating that will prevent bacteria from colonizing the surface. Local and site-specific treatment with long term effect instead of systemic treatment implies improved patient management and citizen well-fare.